Opioid-induced delay in gastric emptying: a peripheral mechanism in humans.
AffiliationCork University Hospital, Wilton, Cork City, Ireland.
Gastric Emptying/*drug effects
Naltrexone/*analogs & derivatives/pharmacology
Quaternary Ammonium Compounds
MetadataShow full item record
CitationAnesthesiology. 1997 Oct;87(4):765-70.
AbstractBACKGROUND: Opioids delay gastric emptying, which in turn may increase the risk of vomiting and pulmonary aspiration. Naloxone reverses this opiate action on gastric emptying, but it is not known whether this effect in humans is mediated by central or peripheral opiate antagonism. The importance of peripheral opioid receptor antagonism in modulating opioid-induced delay in gastric emptying was evaluated using methylnaltrexone, a quaternary derivative of the opiate antagonist naltrexone, which does not cross the blood-brain barrier. METHODS: In a randomized, double-blind, crossover placebo-controlled study, 11 healthy volunteers were given either placebo (saline), 0.09 mg/kg morphine, or 0.09 mg/kg morphine plus 0.3 mg/kg methylnaltrexone on three separate occasions before ingesting 500 ml deionized water. The rate of gastric emptying was measured by two methods: a noninvasive epigastric bioimpedance technique and the acetaminophen absorption test. RESULTS: The epigastric bioimpedance technique was sufficiently sensitive to detect opioid-induced changes in the rate of gastric emptying. The mean +/- SD time taken for the gastric volume to decrease to 50% (t0.5) after placebo was 5.5 +/- 2.1 min. Morphine prolonged gastric emptying to (t0.5) of 21 +/- 9.0 min (P < 0.03). Methylnaltrexone given concomitantly with morphine reversed the morphine-induced delay in gastric emptying to a t0.5 of 7.4 +/- 3.0 (P < 0.04). Maximum concentrations and area under the concentration curve from 0 to 90 min of serum acetaminophen concentrations after morphine were significantly different from placebo and morphine administered concomitantly with methylnaltrexone (P < 0.05). No difference in maximum concentration or area under the concentration curve from 0 to 90 min was noted between placebo and methylnaltrexone coadministered with morphine. CONCLUSIONS: The attenuation of morphine-induced delay in gastric emptying by methylnaltrexone suggests that the opioid effect is mediated outside the central nervous system. Methylnaltrexone may have the potential to decrease the side effects of opioid medications, which are mediated peripherally, while maintaining the central analgesia effect of the opioid.
- A comparison of the effects of tramadol and morphine on gastric emptying in man.
- Authors: Murphy DB, Sutton A, Prescott LF, Murphy MB
- Issue date: 1997 Dec
- The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time.
- Authors: Yuan CS, Foss JF, Osinski J, Toledano A, Roizen MF, Moss J
- Issue date: 1997 Apr
- Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial.
- Authors: Yuan CS, Foss JF, O'Connor M, Toledano A, Roizen MF, Moss J
- Issue date: 1996 Apr
- Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial.
- Authors: Yuan CS, Wei G, Foss JF, O'Connor M, Karrison T, Osinski J
- Issue date: 2002 Jan
- The effects of morphine and methylnaltrexone on gastrointestinal pain in healthy male participants.
- Authors: Brokjaer A, Olesen AE, Christrup LL, Dahan A, Drewes AM
- Issue date: 2015 May